Herold Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$6.38 - $18.33 $12,760 - $36,660	-2,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$12.38 - $19.1 $24,760 - $38,200	2,000 New	2,000 $33,000
Q4 2021 Jan 20, 2022	SELL	$16.55 - $27.63 $33,100 - $55,260	-2,000 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$20.35 - $26.63 $40,700 - $53,260	2,000 New	2,000 $49,000

316

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.